Conferences  >  Medicine & Healthcare  >  Oncology  >  United States

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Continuing Medical Education (CME),    Hematology

Binaytara Foundation

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

oncology, CME-credits

Binaytara Foundation

This program, the Santa Fe Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology.

Email: taylor.s@binayfoundation.org

precision oncology, oncology, cme, cme conference, oncology conference, binaytara foundation, cancer care, cancer, cancer disparities, nonprofit organization, symposium

Binaytara Foundation

This CME-accredited activity, “2023 Global Oncology Summit: Focus on Sustainability”, is a half-day hybrid conference featuring didactics, panel discussions, and abstract presentations. The expert faculty will provide a comprehensive overview of the sustainable approach to establishing global oncology programs in low and middle-income countries (LMIC). They will discuss the challenges and evidence-based solutions to tackle these issues.

Email: taylor.s@binayfoundation.org

oncology, sustainability, cme conference, binaytara foundation, cancer, global oncology,

Binaytara Foundation

This CME-accredited activity, PARP Inhibitors in Prostate Cancer – Recent Updates and Implications for Clinical Practice, is designed to provide expert interpretation of new and emerging data on the treatment of prostate cancer with PARP inhibitors (PARPi) as a single agent or potential new combination treatments, the maintenance setting.

Phone: [4256160572];     Email: taylor.s@binayfoundation.org

parp, parp inhibitors, prostate cancer, binaytara foundation, dr. binay shah, continuing medical education, cme, cme conference

Binaytara Foundation

This program, the Salt Lake City Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology.

Email: taylor.s@binayfoundation.org

oncology, cme conference, cme, oncology conference, precision oncology, binaytara foundation

Cleveland Clinic

The 24th Annual Brain Tumor Update and the 13th Annual Symposium on Brain Metastases and Spine Tumors is co-provided by Cleveland Clinic and Keck School of Medicine of the University of Southern California. This advanced multidisciplinary meeting is led by expert faculty from Cleveland Clinic and USC, with additional internationally recognized guest faculty. This symposium is designed to improve competence to assess and treat patients with brain tumors and tumors of the spine, especially as it relates to comparing treatments for brain metastases and spine tumors, evaluating new technologies, treating meningiomas, and assessing and treating gliomas, with the overall goal of improving outcomes in these patient populations.

Email: eatonl3@ccf.org

neurosurgery, neurology, oncology, radio surgery, brain tumors, brain metastases

Neurology,    Surgery